Wolverine Asset Management LLC Intercept Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Asset Management LLC

$4.35 Billion
Q3 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 07, 2023	BUY	$9.17 - $19.29 $3,668 - $7,716	400 Added 133.33%	700 $7,000
Q1 2023 May 08, 2023	SELL	$12.53 - $21.71 $1.24 Million - $2.15 Million	-99,200 Reduced 99.7%	300 $4,000
Q2 2022 Aug 03, 2022	SELL	$11.23 - $19.59 $3,369 - $5,877	-300 Reduced 0.3%	99,500 $1.37 Million
Q1 2022 May 04, 2022	SELL	$13.37 - $17.79 $1.79 Million - $2.38 Million	-134,000 Reduced 57.31%	99,800 $1.62 Million
Q4 2021 Feb 09, 2022	BUY	$14.28 - $19.53 $31,416 - $42,966	2,200 Added 0.95%	233,800 $3.81 Million
Q3 2021 Nov 12, 2021	BUY	$12.99 - $20.47 $20,784 - $32,752	1,600 Added 0.7%	231,600 $3.44 Million
Q2 2021 Aug 13, 2021	SELL	$15.46 - $24.5 $126,772 - $200,900	-8,200 Reduced 3.44%	230,000 $4.59 Million
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $46,391 - $90,600	-2,400 Reduced 1.0%	238,200 $5.5 Million
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $587,520 - $1.02 Million	24,000 Added 11.08%	240,600 $5.94 Million
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $1.49 Million - $2.04 Million	38,100 Added 21.34%	216,600 $8.98 Million
Q2 2020 Aug 13, 2020	BUY	$46.7 - $92.04 $3.24 Million - $6.39 Million	69,400 Added 63.61%	178,500 $8.55 Million
Q1 2020 May 13, 2020	SELL	$48.35 - $118.68 $4.53 Million - $11.1 Million	-93,600 Reduced 46.18%	109,100 $6.87 Million
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $172,080 - $372,300	-3,000 Reduced 1.46%	202,700 $25.1 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $5.19 Million - $7.11 Million	88,400 Added 75.36%	205,700 $13.7 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $4.29 Million - $6.66 Million	55,200 Added 88.89%	117,300 $9.33 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $1.18 Million - $1.56 Million	12,900 Added 26.22%	62,100 $6.95 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $2.73 Million - $4.02 Million	31,800 Added 182.76%	49,200 $4.96 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $1.54 Million - $2.22 Million	17,400 New	17,400 $2.2 Million
Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $2.16 Million - $2.76 Million	-41,000 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $646,020 - $807,636	-11,100 Reduced 21.31%	41,000 $2.4 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $2.06 Million - $4.3 Million	36,200 Added 227.67%	52,100 $3.02 Million
Q2 2017 Aug 14, 2017	BUY	N/A	15,900	15,900 $1.93 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Account